HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine

Abstract

Background CD8+ T cell-mediated adaptive cellular immunity and natural killer (NK) cell-mediated innate immunity both play important roles in tumour immunity. This study aimed to develop therapeutic tumour vaccines based on double-activation of CD8+ T and NK cells. Methods The immune Epitope database, Molecular Operating Environment software, and enzyme-linked immunosorbent assay were used for epitope identification. Flow cytometry, confocal microscopy, UPLC-QTOF-MS, and RNA-seq were utilized for evaluating immunity of PBMC-derived DCs, CD8+ T or NK cells and related pathways. HLA-A2.1 transgenic mice combined with immunologically reconstituted tumour-bearing mice were used to examine the antitumour effect and safety of epitope vaccines. Results We identified novel HLA-A2.1-restricted extracellular matrix protein 1(ECM1)-derived immunodominant epitopes in which LA induced a potent immune response. We also found that LA-loaded DCs upregulated the frequency of CD3+/CD8+ T cells, CD45RO+/CD69+ activated memory T cells, and CD3−/CD16+/CD56+ NK cells. We demonstrated cytotoxic granule release of LA/DC-CTLs or LA/DC-NK cells and cytotoxicity against tumour cells and microtissue blocks via the predominant IFN-γ/perforin/granzyme B cell death pathway. Further investigating the mechanism of LA-mediated CD8+ T activation, we found that LA could be internalized into DCs through phagocytosis and then formed a LA-MHC-I complex presented onto the DC surface for recognition of the T cell receptor to upregulate Zap70 phosphorylation levels to further activate CD8+ T cells by DC-CTL interactions. In addition, LA-mediated DC-NK crosstalk through stimulation of the TLR4-p38 MAPK pathway increased MICA/B expression on DCs to interact with NKG2D for NK activation. Promisingly, LA could activate CD8+ T cells and NK cells simultaneously via interacting with DCs to suppress tumours in vivo. Moreover, the safety of LA was confirmed. Conclusions LA-induced immune antitumour activity through DC cross-activation with CD8+ T and NK cells, which demonstrated proof-of-concept evidence for the capability and safety of a novel therapeutic tumour vaccine.

The Structural Characterization and Immunomodulatory Activity of Polysaccharides from Pleurotus abieticola Fruiting Bodies

“…High dosages of CTX reduce the number of dendritic cells (DCs) and alter the polarization of Th cells, inducing immunosuppression [ 31 ]. The DCs of CD8 + T and CD56 + NK cells are activated, enhancing the cross-activation of adaptive and innate immune responses [ 32 ]. Polysaccharides from Pleurotus eryngii with a branch of β-1,6-glucan increase the proportion of CD4 T and CD8 T cells to improve immunity [ 33 ].…”

Ultrasound combined with microbubble mediated immunotherapy for tumor microenvironment

“…In addition, NK cells are essential for T cells to mediate tumor immunity. Studies have found that the clearance of NK cells also caused a reduction in the recruitment and activation of tumor specific CD8+T cells ( André et al, 2018 ; Yu et al, 2021 ). Sta Maria et al reported ( Sta Maria et al, 2015 ), in the xenograft tumor of human colorectal adenocarcinoma mice, compared with the group that did not receive ldbFUS treatment, the group that injected MBs + NK cells into the tail vein of mice and underwent ultrasound irradiation had significantly more NK cell aggregation.…”

Novel potential therapeutic targets of alopecia areata

“…iNKT cells are CD1d-restricted, lipid-reactive T cells with predominantly immunomodulatory properties to produce cytokines and chemokines and modulate other immune cells ( 84 ). Additionally, iNKT cells can provide cytotoxic immune responses via cytotoxic granules and death receptor pathways ( 85 ). In arthritis, some iNKT are promoted while others are suppressed.…”